Work

The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs

Year: 2017

Type: review

Source: Molecular Pharmacology

DOI: 10.1124/mol.116.107607

Authors: Mario Rossi, Irene Fasciani, Francesco Marampon, Roberto Maggio, Marco Scarselli

Institutions: University of Pisa, National Institutes of Health, University of L'Aquila, National Institute of Diabetes and Digestive and Kidney Diseases

Language: English

Topic: Receptor Mechanisms and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

OpenAlex ID: W2594896568

FWCI: 0.537

Cites: 62

Cited by: 35

Related to: 10